Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
Authors
Keywords
-
Journal
ARTHRITIS CARE & RESEARCH
Volume 64, Issue 11, Pages 1720-1729
Publisher
Wiley
Online
2012-06-06
DOI
10.1002/acr.21750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
- (2011) C. Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis
- (2011) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Interleukin 6 Blockade as Steroid-sparing Treatment for 2 Patients with Giant Cell Arteritis
- (2011) S. SCIASCIA et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab: a novel therapy for patients with large-vessel vasculitis
- (2011) C. Salvarani et al. RHEUMATOLOGY
- Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
- (2011) Rene Thonhofer et al. RHEUMATOLOGY INTERNATIONAL
- The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
- (2010) Gene G. Hunder et al. ARTHRITIS AND RHEUMATISM
- The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
- (2010) William P. Arend et al. ARTHRITIS AND RHEUMATISM
- Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
- (2010) Jiusheng Deng et al. CIRCULATION
- Mycophenolate mofetil in Takayasu’s arteritis
- (2010) Ruchika Goel et al. CLINICAL RHEUMATOLOGY
- Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica
- (2010) K. HAGIHARA et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review
- (2010) J. A. SINGH et al. JOURNAL OF RHEUMATOLOGY
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells
- (2010) J. J. O'Shea et al. SCIENCE
- Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis
- (2010) Ana García-Martínez et al. ARTHRITIS CARE & RESEARCH
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
- (2009) Miho Suzuki et al. RHEUMATOLOGY INTERNATIONAL
- Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up
- (2008) E S Molloy et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of large vessel vasculitis
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
- (2008) Norihiro Nishimoto et al. ARTHRITIS AND RHEUMATISM
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Giant cell arteritis and polymyalgia rheumatica: Role of cytokines in the pathogenesis and implications for treatment
- (2008) Victor Manuel Martinez-Taboada et al. CYTOKINE
- Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production
- (2008) Yasushi Uchiyama et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
- (2008) T. Korn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search